Archives

by in
Entry Author Date Location
Alkermes CEO Richard Pops on Building Big, Playing Well with Pharma 04/18/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
How Alkermes Survived a Brush With Death 11/11/13 National
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
East Coast Life Sciences Roundup: Alkermes, Ensemble, Sinai, & More 07/19/13 Boston
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Alkermes Unveils Full Mid-Stage Data On Depression Drug 05/31/13 Boston
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Biotech CEOs See Insurers as the New Boogeymen, Not FDA 01/07/13 National
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds 01/03/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News 07/08/11 Boston
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech” 07/06/11 Boston
Why Twitter Matters Now in Biotech, and Why Executives Can’t Ignore it Anymore 06/13/11 National
Alkermes Acquires Elan Drug Manufacturing Unit for $960M 05/09/11 Boston
Biotech’s Missed Opportunity: Small-Town and Rural America 04/18/11 National
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference 04/14/11 Boston
Alkermes Sees Chance to Reinvent Vivitrol For Fighting Drug Addiction, Not Just Alcoholism 02/18/11 Boston
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout 01/10/11 Boston
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box 11/15/10 Boston
Alkermes Wins FDA Panel Nod 09/16/10 Boston
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News 06/25/10 Boston
Page 1 of 2 next page »